Ganoderic acid Df

• Description :

  Ganoderic acid Df is a lanostane-type triterpenoid, that can be isolated from the fruiting body of Ganoderma lucidum. Ganoderic acid Df potently inhibits aldose reductase, with an IC50 of 22.8 ± 0.6 μM[1].

• UNSPSC :

  12352211

• Target :

  Aldose Reductase

• Type :

  Natural Products

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/ganoderic-acid-df.html

• Solubility :

  10 mM in DMSO

• Smiles :

  C[C@]12C3=C([C@H](C[C@@]1([C@@](CC2=O)([H])[C@H](C)CC(CC(C)C(O)=O)=O)C)O)[C@@]4([C@@](C(C)(C(CC4)=O)C)([H])C[C@@H]3O)C

• Molecular Formula :

  C30H44O7

• Molecular Weight :

  516.67

• References & Citations :

  [1]Fatmawati S, et al. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum. Fitoterapia. 2010 Dec;81 (8) :1033-6.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [1352033-73-8]